Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin

Journal of Pharmacokinetics and Biopharmaceutics
J G WAGNER, J W Ayres

Abstract

No abstract listed.

References

Oct 1, 1976·Clinical Pharmacology and Therapeutics·R P JuhlD D Brown
Jan 1, 1975·Clinical Pharmacology and Therapeutics·D J GreenblattJ Koch-Weser
Jan 1, 1976·Clinical Pharmacokinetics·D J GreenblattJ Koch-Weser
Jun 1, 1977·Steroids·J G WAGNERJ W Ayres
Sep 1, 1976·Clinical Pharmacology and Therapeutics·F I MarcusR Bressler
Jul 1, 1976·Journal of Pharmaceutical Sciences·P H Hinderling
Oct 1, 1976·Journal of Pharmaceutical Sciences·J R Howell
Jan 1, 1975·Clinical Pharmacology and Therapeutics·R G Stoll, J G WAGNER
Jun 1, 1975·Journal of Pharmacokinetics and Biopharmaceutics·J R KoupJ Koch-Weser
Sep 1, 1975·Journal of Pharmaceutical Sciences·E G LoveringW Tostowaryk
Jun 13, 1975·European Journal of Clinical Pharmacology·T BeveridgeR Schmidt
Jun 1, 1976·Clinical Pharmacology and Therapeutics·B F JohnsonG A Sabey
Sep 1, 1974·Clinical Pharmacology and Therapeutics·D J GreenblattT W Smith
Nov 1, 1974·Clinical Pharmacology and Therapeutics·D J GreenblattT W Smith
Nov 20, 1972·JAMA : the Journal of the American Medical Association·D H Huffman, D L Azarnoff
Apr 9, 1973·JAMA : the Journal of the American Medical Association·J G WAGNERR G Stoll
Oct 20, 1973·British Medical Journal·N SanchezK L Melmon
Nov 10, 1973·British Medical Journal·B F JohnsonA D Munro-Faure
May 1, 1974·Clinical Pharmacology and Therapeutics·D J GreenblattT W Smith
Aug 1, 1974·Journal of Pharmaceutical Sciences·P R KlinkR H McDonald

Citations

Oct 1, 1985·European Journal of Drug Metabolism and Pharmacokinetics·J A Morais, J G WAGNER
Jan 1, 1981·Pharmacology & Therapeutics·D Cutler
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·R PähklaL Rootslane
Dec 30, 1982·The New England Journal of Medicine
Jun 1, 1977·Steroids·J G WAGNERJ W Ayres
Aug 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·J NewburgerS Stavchansky
Aug 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·W W Piegorsch, A J Bailer
May 1, 1980·Journal of Clinical Pharmacology·L M AllenJ Denefrio
Oct 1, 1984·Biopharmaceutics & Drug Disposition·J A Morais, J G WAGNER
Jan 1, 1980·Biopharmaceutics & Drug Disposition·J Newburger, S Stavchansky
Apr 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·J G WAGNERA Yacobi
Jul 1, 1981·British Journal of Haematology·S G BarrettD F Bainton
Jan 1, 1981·European Journal of Clinical Pharmacology·M T Smith, T C Smith
Aug 1, 1981·British Journal of Clinical Pharmacology·L E MatherP J McDonald
Apr 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·J G WAGNERH Movahhed
Aug 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio, D Katz

Related Concepts

Biological Availability
Biopharmaceutics
Mapluxin
Mathematics

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.